Neuropsychiatric Symptoms in HIV Patients after Switching from Nevirapine to Dolutegravir in Cipto Mangunkusumo Hospital, Jakarta

Introduction. Dolutegravir (DTG) is one of the effective antiretroviral therapies (ART) for suppressing HIV replication and has a favorable safety profile. However, reports regarding neuropsychiatric side effects, especially in patients transitioning from a nevirapine (NVP) regimen to dolutegravir,...

詳細記述

書誌詳細

主要な著者:	Metra Adi Pratama, Rudi Putranto, Herqutanto Herqutanto, Aisyah Syahrani, Veritea Natali, Aljira Fitya Hapsari, Meivina Ramadhani Pane, Evy Yunihastuti
フォーマット:	Artigo
言語:	Indonésio
出版事項:	Department of Internal Medicine, Faculty of Medicine Universitas Indonesia 2025-06-01
シリーズ:	Jurnal Penyakit Dalam Indonesia
主題:	arv art dolutegravir hiv neuropsychiatric nevirapine
オンライン･アクセス:	https://scholarhub.ui.ac.id/jpdi/vol12/iss2/4/
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!